File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

TitleCost-effectiveness analysis of first-line treatment for chronic hepatitis B in China
Authors
DAI, ZWong, OLXie, CXu, WXiang, YPeng, LLau, EHY
Issue Date2021
Citation
Clinical Microbiology and Infection, 2021, S1198-743X n. 21, p. 00344-X How to Cite?
DOI: http://dx.doi.org/10.1016/j.cmi.2021.06.024
Persistent Identifierhttp://hdl.handle.net/10722/304605
ISI Accession Number ID
WOS:000747878400025

 

DC FieldValueLanguage
dc.contributor.authorDAI, Z-
dc.contributor.authorWong, OL-
dc.contributor.authorXie, C-
dc.contributor.authorXu, W-
dc.contributor.authorXiang, Y-
dc.contributor.authorPeng, L-
dc.contributor.authorLau, EHY-
dc.date.accessioned2021-10-05T02:32:32Z-
dc.date.available2021-10-05T02:32:32Z-
dc.date.issued2021-
dc.identifier.citationClinical Microbiology and Infection, 2021, S1198-743X n. 21, p. 00344-X-
dc.identifier.urihttp://hdl.handle.net/10722/304605-
dc.languageeng-
dc.relation.ispartofClinical Microbiology and Infection-
dc.titleCost-effectiveness analysis of first-line treatment for chronic hepatitis B in China-
dc.typeArticle-
dc.identifier.emailWong, OL: iolwong@hku.hk-
dc.identifier.emailLau, EHY: ehylau@hku.hk-
dc.identifier.authorityWong, OL=rp01806-
dc.identifier.authorityLau, EHY=rp01349-
dc.identifier.doi10.1016/j.cmi.2021.06.024-
dc.identifier.scopuseid_2-s2.0-85110472320-
dc.identifier.hkuros326368-
dc.identifier.issue21-
dc.identifier.spage00344-
dc.identifier.epageX-
dc.identifier.isiWOS:000747878400025-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats